← All organizations
Institut Paoli-Calmettes
Academic/HospitalWebsite ↗
Also known as: Institute Paoli-Calmettes | Institut Paoli Calmette Marseille | Institut Paoli-Calmettes | Institut Paoli Calmettes - Marseille | Institut Paoli Calmettes-Marseille | Institut Paoli-Calmettes, Marseille | Institut-Paoli Calmettes Marseille | Institut Paoli Calmettes Marseille France | Institut Paoli Calmettes, Marseille, France | Institut Paoli-Calmettes, Marseille, France | Institut Paoli et Calmette (Marseille)
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2000Last known activity
Oct 31, 2025
Timeline
1920s
- Jun 1, 1923
Institut Paoli-Calmettes— Founded
Drugs by trial phase (77 distinct, 64 trials)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (44 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Colorectal Neoplasms
- Esophageal Neoplasms
- Graft vs Host Disease
- Hematologic Diseases
- Inflammatory Breast Neoplasms
- Invasive Fungal Infections
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Mycoses
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Pancreatic Neoplasms
- Plasmacytoma
- Precancerous Conditions
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Stomach Neoplasms
- Syndrome
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT07151586OfficialPhase 2Oct 31, 2025
- NCT06846346OfficialPhase 2Sep 30, 2025
- NCT06557421Lead sponsorPhase 2Nov 1, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT05986071Lead sponsorPhase 1/Phase 2Apr 1, 2024
- NCT06066255Lead sponsorPhase 2Mar 31, 2024
- NCT06055621Lead sponsorPhase 2Dec 31, 2023
- NCT05782127Overall official - principal investigatorPhase 1/Phase 2Nov 30, 2023
- NCT05782127OfficialPhase 1/Phase 2Nov 30, 2023
- NCT05519670Lead sponsorPhase 1/Phase 2Mar 31, 2023
- NCT05211570OfficialPhase 1/Phase 2Jun 1, 2022
- NCT05143970Lead sponsorPhase 1Nov 29, 2021
- NCT05143970Overall official - principal investigatorPhase 1Nov 29, 2021
- NCT04827719Overall official - principal investigatorPhase 2May 1, 2021
- NCT04451200Lead sponsorPhase 2Nov 30, 2020
Details
- Founded
- Marseilles, FR Jun 1, 1923
- Last known activity
- Oct 31, 2025